India’s Pharma Giants Brace for Margin Squeeze as Trump’s Drug Import Order Sets 25% Tariff Ceiling
Trump's August 1 pharmaceutical import order, threatening 25% tariffs, split India's drug index Thursday: domestic-oriented names held gains while US-revenue-heavy companies Sun Pharma, Dr Reddy's and Lupin fell as investors priced a

Follow